Form 4 filings across 10 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$1.1B
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 25 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 58 most recent Form 4 transactions.
| $0 |
| +$30M |
| 5.1M |
| May 11 |
| ZBIO | Zenas BioPharma, Inc. | $9M | $0 | +$9M | 2.4M | Mar 31 |
| COGT | Cogent Biosciences, Inc. | $25M | $370M | -$345M | 5.5M | Mar 31 |
| DMRA | Damora Therapeutics, Inc. | $0 | $0 | $0 | 2.9M | Mar 23 |
| Sep 3 | APGE | Apogee Therapeutics, Inc. | DTOISS◆ | 14,461 | — | — | — | Open the original filing on SEC.gov |
| Sep 3 | APGE | Apogee Therapeutics, Inc. | DTOISS◆ | 10,370 | — | — | — | Open the original filing on SEC.gov |
| Sep 3 | APGE | Apogee Therapeutics, Inc. | DTOISS◆ | 47,758 | — | — | — | Open the original filing on SEC.gov |
| Sep 3 | APGE | Apogee Therapeutics, Inc. | DTOISS◆ | 6.7M | — | — | — | Open the original filing on SEC.gov |
| Sep 3 | APGE | Apogee Therapeutics, Inc. | DTOISS | 51,166 | — | — | -100.0% | Open the original filing on SEC.gov |
| Sep 3 | APGE | Apogee Therapeutics, Inc. | DTOISS | 51,166 | — | — | -100.0% | Open the original filing on SEC.gov |
| Sep 3 | APGE | Apogee Therapeutics, Inc. | DTOISS | 340,855 | — | — | -100.0% | Open the original filing on SEC.gov |
| Aug 7 | APGE | Apogee Therapeutics, Inc. | MEXER◆ | 10,370 | — | — | — | Open the original filing on SEC.gov |
| Aug 7 | APGE | Apogee Therapeutics, Inc. | MEXER◆ | 31,838 | — | — | — | Open the original filing on SEC.gov |
| Aug 7 | APGE | Apogee Therapeutics, Inc. | MEXER | 10,370 | $43.85 | $454.7K | +3.1% | Open the original filing on SEC.gov |
| Aug 7 | APGE | Apogee Therapeutics, Inc. | MEXER | 31,838 | $17.00 | $541.2K | +10.7% | Open the original filing on SEC.gov |
| Jul 16 | CBIO | Crescent Biopharma, INC. | PDBUY◆ | 525,897 | $14.50 | $7.6M | — | Open the original filing on SEC.gov |
| Jul 16 | CBIO | Crescent Biopharma, INC. | PBUY | 853,450 | $14.50 | $12.4M | +31.1% | Open the original filing on SEC.gov |
| Jul 1 | ORKA | Oruka Therapeutics, Inc. | CCONV◆ | 42,641 | — | — | — | Open the original filing on SEC.gov |
| Jul 1 | ORKA | Oruka Therapeutics, Inc. | SSELL | 3.6M | $84.43 | $300M | -75.8% | Open the original filing on SEC.gov |
| Jul 1 | ORKA | Oruka Therapeutics, Inc. | CCONV | 3.6M | — | — | +313.9% | Open the original filing on SEC.gov |
| Jun 23 | SYRE | Spyre Therapeutics, Inc. | CCONV◆ | 16,667 | — | — | — | Open the original filing on SEC.gov |
| Jun 23 | SYRE | Spyre Therapeutics, Inc. | SSELL | 4.7M | $85.31 | $399.7M | -100.0% | Open the original filing on SEC.gov |
| Jun 23 | SYRE | Spyre Therapeutics, Inc. | CCONV | 666,680 | — | — | +16.6% | Open the original filing on SEC.gov |
| Jun 9 | JBIO | Jade Biosciences, Inc. | AGRANT◆ | 34,843 | — | — | — | Open the original filing on SEC.gov |
| Jun 9 | APGE | Apogee Therapeutics, Inc. | AGRANT◆ | 7,657 | — | — | — | Open the original filing on SEC.gov |
| Jun 2 | ORKA | Oruka Therapeutics, Inc. | AGRANT◆ | 9,136 | — | — | — | Open the original filing on SEC.gov |
| Jun 2 | CBIO | Crescent Biopharma, INC. | AGRANT◆ | 11,050 | — | — | — | Open the original filing on SEC.gov |
| May 27 | SYRE | Spyre Therapeutics, Inc. | AGRANT◆ | 8,026 | — | — | — | Open the original filing on SEC.gov |
| May 11 | VRDN | Viridian Therapeutics,… | PBUY | 1.2M | $17.00 | $20M | +30.0% | Open the original filing on SEC.gov |
| Mar 31 | COGT | Cogent Biosciences, Inc. | CCONV◆ | 28,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 31 | COGT | Cogent Biosciences, Inc. | SSELL | 7M | $34.66 | $242.6M | -56.0% | Open the original filing on SEC.gov |
| Mar 31 | COGT | Cogent Biosciences, Inc. | CCONV | 7M | — | — | +127.2% | Open the original filing on SEC.gov |
| Mar 31 | ZBIO | Zenas BioPharma, Inc. | PBUY | 150,000 | $20.00 | $3M | +6.8% | Open the original filing on SEC.gov |
| Mar 23 | DMRA | Damora Therapeutics, Inc. | AGRANT◆ | 37,313 | — | — | — | Open the original filing on SEC.gov |
| Feb 9 | DMRA | Damora Therapeutics, Inc. | MEXER◆ | 2,904 | — | — | — | Open the original filing on SEC.gov |
| Feb 9 | DMRA | Damora Therapeutics, Inc. | MEXER◆ | 5,809 | — | — | — | Open the original filing on SEC.gov |
| Feb 9 | DMRA | Damora Therapeutics, Inc. | MEXER | 2.9M | — | — | — | Open the original filing on SEC.gov |
| Feb 9 | DMRA | Damora Therapeutics, Inc. | MEXER | 5.8M | — | — | — | Open the original filing on SEC.gov |
| Jan 22 | COGT | Cogent Biosciences, Inc. | SSELL | 3.5M | $36.40 | $127.4M | -38.9% | Open the original filing on SEC.gov |
| Jan 22 | APGE | Apogee Therapeutics, Inc. | SSELL | 1.8M | $76.30 | $133.5M | -85.4% | Open the original filing on SEC.gov |
| Dec 4, 2025 | CBIO | Crescent Biopharma, INC. | PDBUY◆ | 131,434 | $13.41 | $1.8M | — | Open the original filing on SEC.gov |
| Dec 4, 2025 | CBIO | Crescent Biopharma, INC. | PBUY | 1.4M | $13.41 | $18.2M | +98.0% | Open the original filing on SEC.gov |
| Oct 23, 2025 | VRDN | Viridian Therapeutics,… | PBUY | 454,545 | $22.00 | $10M | +13.1% | Open the original filing on SEC.gov |
| Oct 7, 2025 | ZBIO | Zenas BioPharma, Inc. | PBUY | 316,219 | $19.00 | $6M | +16.7% | Open the original filing on SEC.gov |
| Oct 6, 2025 | JBIO | Jade Biosciences, Inc. | AGRANT◆ | 855,047 | $9.14 | $7.8M | — | Open the original filing on SEC.gov |
| Oct 6, 2025 | JBIO | Jade Biosciences, Inc. | AGRANT | 1.3M | $9.14 | $12.2M | +236.1% | Open the original filing on SEC.gov |
| Sep 17, 2025 | ORKA | Oruka Therapeutics, Inc. | AGRANT | 333,340 | $15.00 | $5M | +41.7% | Open the original filing on SEC.gov |
| Jul 10, 2025 | COGT | Cogent Biosciences, Inc. | PBUY | 2.8M | $9.00 | $25M | +44.6% | Open the original filing on SEC.gov |
| Jun 23, 2025 | CBIO | Crescent Biopharma, INC. | AGRANT◆ | 9,023 | — | — | — | Open the original filing on SEC.gov |
| Jun 17, 2025 | APGE | Apogee Therapeutics, Inc. | AGRANT◆ | 14,461 | — | — | — | Open the original filing on SEC.gov |
| Jun 17, 2025 | APGE | Apogee Therapeutics, Inc. | AGRANT◆ | 14,461 | — | — | — | Open the original filing on SEC.gov |
| Jun 10, 2025 | VRDN | Viridian Therapeutics,… | MEXER◆ | 12,500 | — | — | — | Open the original filing on SEC.gov |
| Jun 10, 2025 | VRDN | Viridian Therapeutics,… | MEXER | 12,500 | $12.31 | $153.9K | +0.4% | Open the original filing on SEC.gov |
| Jun 10, 2025 | ZBIO | Zenas BioPharma, Inc. | AGRANT◆ | 18,500 | — | — | — | Open the original filing on SEC.gov |
| Jun 9, 2025 | VRDN | Viridian Therapeutics,… | MEXER◆ | 1,600 | — | — | — | Open the original filing on SEC.gov |
| Jun 9, 2025 | VRDN | Viridian Therapeutics,… | MEXER | 1,600 | $7.80 | $12.5K | +<0.1% | Open the original filing on SEC.gov |
| Jun 2, 2025 | ORKA | Oruka Therapeutics, Inc. | AGRANT◆ | 17,500 | — | — | — | Open the original filing on SEC.gov |
| May 29, 2025 | SYRE | Spyre Therapeutics, Inc. | AGRANT◆ | 25,000 | — | — | — | Open the original filing on SEC.gov |
| May 29, 2025 | SYRE | Spyre Therapeutics, Inc. | AGRANT◆ | 25,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 29, 2025 | JBIO | Jade Biosciences, Inc. | AGRANT◆ | 23,017 | — | — | — | Open the original filing on SEC.gov |